<DOC>
	<DOCNO>NCT02840591</DOCNO>
	<brief_summary>Primary aim study assess feasibility conduct clinical research delirium ( confusion due medical problem ) Clements University Hospital Dallas , Texas . A secondary aim ass whether FDA-approved sleep aid call Ramelteon over-the-counter supplement call Citicoline safe beneficial delirium .</brief_summary>
	<brief_title>Ramelteon Citicoline Delirium</brief_title>
	<detailed_description>This 5-day , non-randomized , open-label , consecutive case series ramelteon treatment follow separate consecutive case series citicoline treatment , run parallel non-randomized , observation-only , treatment usual arm hospitalize patient delirium . On drug treatment arm , first five consecutive subject meet Diagnostic Statistical Manual ( DSM ) -5 criteria delirium give ramelteon 8 mg daily bedtime 5 day . The next five consecutive patient give citicoline 250 mg daily bedtime 2 day , follow 500 mg daily bedtime 3 day . Patients observation-only arm screen follow similarly , except give experimental drug . All subject continue receive standard medical care delirium , include optimal medical treatment , psychotropic medication consultation specialty service necessary . The study small pilot see good feasibility , tolerability signal delirium improvement efficacy two medication . The goal develop ability conduct delirium research institution obtain preliminary pilot data . These data use design obtain funding future , large research study . data medication examine look pattern suggest one may preferable research . However , give small sample size , meaningful between-group statistical analysis possible .</detailed_description>
	<mesh_term>Delirium</mesh_term>
	<mesh_term>Cytidine Diphosphate Choline</mesh_term>
	<criteria>Admitted inpatient unit commonly know 12South 12North Clements University Hospital Has capacity give inform consent OR legally authorize representative available bedside Expected duration hospitalization longer 48 hour Fluent English Can screen study physician within 24 hour admission History angioedema allergic reaction previous ramelteon therapy Pregnant currently breastfeed Concurrent use fluvoxamine Severe hepatic impairment Severe obstructive sleep apnea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Citicoline , Ramelteon , Rozerem</keyword>
</DOC>